Start free

Larimar Therapeutics, Inc. (LRMR) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 18, 2026.

Filings shown
17
Open-market buys
10
Open-market sells
0
Buys, 10b5-1 box not checked
10 of 10

Counts cover the 17 most recent Form 4 filings Tradune holds for LRMR (filed May 20 – Nov 18, 2026); the score below covers only the trailing 90 days (9 buys, 0 sells). SEC EDGAR Form 4 filings for LRMR last checked Nov 21, 2026, 09:00 UTC; the latest LRMR filing Tradune holds was filed Nov 18, 2026. This is not guaranteed to be the complete record — see LRMR's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 10 filings Tradune holds for LRMR filed Oct 1 – Nov 18, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Thomas Edward HamiltonDirector 1 0 70,000 — +$187,082
Michael CelanoChief Financial Officer 1 0 18,460 — +$49,992
Carole Ben-MaimonPresident and CEO 1 0 18,050 — +$49,953
John B. Harlow Jr.President and COO 1 0 17,800 — +$49,918
Frank E. ThomasDirector 1 0 8,000 — +$21,800
Gopi ShankarChief Development Officer 1 0 5,000 — +$13,549
Joseph TruittDirector 1 0 3,500 — +$9,792
Russell ClaytonChief Medical Officer 1 0 3,322 — +$9,999
Jeffrey W. ShermanDirector 1 0 3,289 — +$10,058

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

100/ 100

Purchase cluster incl. officer
9 distinct buyers9 buy · 0 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

Weekly signal history

LRMR appeared in 1 archived weekly edition as a multi-insider cluster, a top net buyer, or both. These are frozen weekly snapshots, not a complete filing history.

  1. Week of Nov 17, 2026
    8 insiders buying · $392,144 net

An entry means this company met that edition’s displayed cluster or top-buyer threshold. Missing weeks do not mean no insider transaction occurred. All figures are derived from SEC Form 4 filings; open-market buys minus sales are shown as net only when every transaction value was disclosed.

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at LRMR

Insiders reported 10 open-market purchases of LRMR between May 20, 2026 and Nov 18, 2026, across 9 distinct buyers. The most recent purchase was reported by Jeffrey W. Sherman (Director) on Nov 16, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Russell Clayton Chief Medical Officer · filed Nov 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 3,322 $3.01 74,765 +4.6% Nov 16, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Jeffrey W. Sherman Director · filed Nov 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 3,289 $3.06 8,289 +66% Nov 16, 2026
Thomas Edward Hamilton Director · filed Nov 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 70,000 $2.67 70,000 (indirect) — Nov 12, 2026
Carole Ben-Maimon President and CEO · filed Nov 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 18,050 $2.77 386,326 +4.9% Nov 11, 2026
Frank E. Thomas Director · filed Nov 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 8,000 $2.73 15,000 +114% Nov 11, 2026
Joseph Truitt Director · filed Nov 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 3,500 $2.80 6,250 +127% Nov 11, 2026
John B. Harlow Jr. President and COO · filed Nov 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 17,800 $2.80 67,800 +36% Nov 11, 2026
Michael Celano Chief Financial Officer · filed Nov 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 18,460 $2.71 234,245 +8.6% Nov 11, 2026
Gopi Shankar Chief Development Officer · filed Nov 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 5,000 $2.71 81,443 +6.5% Nov 11, 2026
John B. Harlow Jr. President and COO · filed Oct 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 50,000 — 50,000 — Sep 29, 2026
Grant / award Stock Option (Right to Buy) 800,000 — — — Sep 29, 2026
Thomas Edward Hamilton Director · filed Jul 8, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 50,000 $3.34 714,798 +7.5% Jul 6, 2026
James E. Flynn Director, 10% owner · filed May 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 55,150 — — — May 19, 2026
Jonathan S. Leff Director · filed May 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 55,150 — — — May 19, 2026
Jeffrey W. Sherman Director · filed May 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 55,150 — — — May 19, 2026
Joseph Truitt Director · filed May 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 55,150 — — — May 19, 2026
Frank E. Thomas Director · filed May 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 55,150 — — — May 19, 2026
Thomas Edward Hamilton Director · filed May 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 55,150 — — — May 19, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to LRMR's (Nov 18, 2026).

Frequently asked about LRMR insider activity

How many insiders bought LRMR stock in these Form 4 filings?

9 distinct insiders at Larimar Therapeutics, Inc. reported 10 open-market purchases (Form 4 code P) of LRMR shares between May 20, 2026 and Nov 18, 2026, the most recent filed by Jeffrey W. Sherman (Director) on Nov 16, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for LRMR?

The most recent Form 4 on this page was filed by Russell Clayton (Chief Medical Officer) on Nov 18, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market LRMR insider purchase shown?

The largest open-market purchase among the filings shown was 70,000 LRMR shares at $2.67 (about $187,082) by Thomas Edward Hamilton (Director) on Nov 12, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent LRMR insider purchases have the Form 4 10b5-1 box checked?

No. All 10 LRMR open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Jeffrey W. Sherman (Director) on Nov 16, 2026, 3,289 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for LRMR — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.